Neuroblastoma Australia welcomed the news today: "On behalf of all families of children impacted by neuroblastoma, we welcome the TGA's decision to approve IFINWIL®. We urgently need treatments for ...

Researchers at the Johns Hopkins Bloomberg School of Public Health contributed to a new Centers for Disease Control and Prevention report examining autism among children who turned 4 and 8 years old ...

New research suggests that calming the brain's immune cells might prevent or lessen the damaging inflammation seen in Alzheimer's disease.

Hydroxyurea remains effective long-term in reducing emergency department visits and hospital days for children living with ...

Researchers from Children's Hospital of Philadelphia (CHOP) and the Perelman School of Medicine at the University of ...

A new study led by researchers at Yale University suggests that early-life exposure to two widespread environmental pollutants- small particle air pollution and outdoor artificial light at night-could ...

The National Institutes of Health's sweeping cuts of grants that fund scientific research are inflicting pain almost universally across the U.S., including in most states that backed President Donald ...

After the Senate voted to confirm Robert F. Kennedy Jr. as Health and Human Services secretary, supporters of his "Make America Healthy Again" movement cheered at having a champion in the federal ...

Crofelemer, a novel plant-based anti-secretory prescription drug, has been granted Orphan Drug Designation by the FDA and the European Medicines ...

Our immune systems weaken as we get older, making fewer cells that fight infection and help us recover from illness and injury. Scientists aren't completely sure why. They may have a better idea now, ...

Zynext Ventures USA LLC today announced its investment in Feldan Therapeutics (Feldan), a Canada-based early clinical-stage ...